semaglutide heart failure reduced ejection fraction Oral found to lower risk of events in people with type 2 diabetes semaglutide #hfpef #obesity #esccongress |

Injectable GLP-1-based therapies, including semaglutide and tirzepatide, have demonstrated substantial benefits for weight loss and cardiometabolic risk reduction ( 1 3 ), but real-world uptake has been shaped by factors such as route of administration, access, tolerability, and insurance coverage ( 4 7 )

Obesity and recurrent spontaneous abortion: the crucial role of weight management in pregnancy

DO NOT FREEZE

For patients with obesity, significant weight loss can result in restored ovulation, more regular periods, and rebalanced estrogen, a hormone that rises with obesity and can diminish fertility

Now, however, she fears she wont be able to afford treatment moving forward